YellowGrade
Pfizer and BioNTech say booster dose provides high level of protection against omicron variant in initial lab study

Dec. 8, 2021, 7:46 a.m.

(CNBC) A third shot shows virus fighting abilities comparable to the protection provided by two-doses against the original strain of the virus.

Login to grade this article.